Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Left Ventricular Hypertrophy

ng-nitroarginine methyl ester has been researched along with Left Ventricular Hypertrophy in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's16 (33.33)18.2507
2000's24 (50.00)29.6817
2010's7 (14.58)24.3611
2020's1 (2.08)2.80

Authors

AuthorsStudies
Hasmono, D; Hijriani, N; Yusetyani, L1
Coelho-Filho, OR; Das, S; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Rosenzweig, A; Shah, RV; Simonson, B1
Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Prachaney, P; Welbat, JU1
Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K1
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA1
Behuliak, M; Celec, P; Hojna, S; Kojsova, S; Kunes, J; Paulis, L; Pechanova, O; Simko, F; Zicha, J1
Rossi, MA1
Bonney, W; Cheema, FH; Gonzalez, AM; Homma, S; Kinnear, C; Liao, JK; Mahmut, N; Martens, TP; Mital, S; Osorio, JC1
Cho, HS; Kim, WK; Lee, J; Park, S1
Chen, WM; Deng, J; Huang, XN; Wang, YW; Wu, Q1
Babál, P; Hlavačková, L; Janega, P; Pecháňová, O; Vranková, S1
Burns, KD; deBlois, D; Hale, TM; Robertson, SJ1
Itoh, M; Kubota, I; Miyamoto, T; Shishido, T; Takahashi, H; Takeishi, Y; Tomoike, H1
Prado, CM; Ramos, SG; Rossi, MA1
Charo, IF; Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Ishibashi, T; Kitamoto, S; Kura, S; Ohtani, K; Sugaya, T; Takeshita, A; Tsuchihashi, M; Tsuzuki, T; Zhao, Q1
Gröne, HJ; Gross, V; Janke, J; Kiss, E; Langenickel, TH; Luft, FC; Mazak, I; Müller, DN; Obst, M; Shagdarsuren, E1
Andriantsitohaina, R; Babál, P; Bernátová, I; Kyselá, S; Martínez, MC; Pechánová, O; Stvrtina, S1
Deuchar, GA; Hicks, MN; MacLean, MR1
Abe, Y; Date, T; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Tanaka, Y; Taniguchi, I; Taniguchi, M1
Babal, P; Bernatova, I; Gvozdjakova, A; Krajcirovicova, K; Kucharska, J; Luptak, I; Matuskova, J; Pechanova, O; Simko, F; Simko, J; Sumbalova, Z1
Jendeková, L; Kojsová, S; Pechánová, O; Sládková, M1
Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F1
Krajcírovicová, K; Lupták, I; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Pincíková, T; Pomsár, J; Simko, F; Stvrtina, S1
Barbosa Neto, O; Blanco, JH; Martin-Pinge, MC; Penteado, DM; Silva, VJ; Souza, HC; Teixeira, Vde P1
Braun-Dullaeus, RC; Ebner, B; Heerwagen, C; Kasper, M; Morawietz, H; Schmeisser, A; Schober, K; Schwencke, C; Strasser, RH; Wunderlich, C1
Adamcova, M; Hulin, I; Janega, P; Krajcirovicova, K; Matuskova, J; Paulis, L; Pechanova, O; Pelouch, V; Potacova, A; Simko, F; Simko, J1
Appay, MD; Arnal, JF; Bariety, J; Hinglais, N; Laboulandine, I; Michel, JB; Xu, Y1
Fujita, H; Itoh, H; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Tanaka, M; Uchida, A1
Arnal, JF; Chatellier, G; el Amrani, AI; Ménard, J; Michel, JB1
Sadoff, JD; Scholz, PM; Tse, J; Weiss, HR1
Endo, T; Hayakawa, H; Kaneko, H; Kiuchi, K1
Bernátová, I; Pechánová, O1
Bernátová, I; Pechánová, O; Simko, F1
Devát, L; Gerová, M; Kristek, F; Varga, I1
Devát, L; Gerová, M; Sládek, T; Znojil, V1
Dolezel, S; Gerová, M; Hartmannová, B; Jezek, L1
Laverty, R; Ledingham, JM1
Anderson, NH; Brosnan, MJ; Clark, JS; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; McPhaden, A; Reid, JL1
Akuzawa, N; Hoshino, J; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H1
Franco, M; Janicki, JS; Matsubara, BB; Matsubara, LS; Zornoff, LA1
Aizawa, H; Akuzawa, N; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H1
Babál, P; Bernátová, I; Pechánová, O1
Antunes, E; Cintra, KA; De Luca, IM; De Nucci, G; de Oliveira, CF; Teixeira, SA1
Bernátová, I; Pechánová, O; Pelouch, V; Simko, F1
Laverty, R; Ledingham, JM; Orange, SJ1
Mandarim-De-Lacerda, CA; Pereira, LM1
Brown, NJ; Fogo, AB; Kaikita, K; Ma, L; Schoenhard, JA; Vaughan, DE1
Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR1

Reviews

1 review(s) available for ng-nitroarginine methyl ester and Left Ventricular Hypertrophy

ArticleYear
Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension.
    Advances in experimental medicine and biology, 1997, Volume: 432

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Susceptibility; Humans; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY

1997

Other Studies

47 other study(ies) available for ng-nitroarginine methyl ester and Left Ventricular Hypertrophy

ArticleYear
The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension.
    Journal of basic and clinical physiology and pharmacology, 2020, Jan-11, Volume: 30, Issue:6

    Topics: Adjuvants, Pharmaceutic; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Curcuma; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; NG-Nitroarginine Methyl Ester; Plant Extracts; Treatment Outcome

2020
Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
    Circulation, 2013, Sep-10, Volume: 128, Issue:11

    Topics: Algorithms; Animals; Aortic Valve Stenosis; Biomarkers; Body Water; Cardiomyopathy, Hypertrophic; Cell Size; Contrast Media; Gadolinium DTPA; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Mice; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Phenotype; Random Allocation; Ventricular Remodeling

2013
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:11

    Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Pentacyclic Triterpenes; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Vascular Remodeling; Ventricular Remodeling

2015
Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    American journal of physiology. Heart and circulatory physiology, 2015, Nov-15, Volume: 309, Issue:10

    Topics: Animals; Aorta; Biopterins; Capillaries; Cell Size; Constriction; Dilatation, Pathologic; Enzyme Inhibitors; Glycine; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidative Stress; Pressure; Pterins; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling

2015
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
    Journal of the American Heart Association, 2016, Jan-14, Volume: 5, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2016
Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:4

    Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Endothelins; Enzyme Inhibitors; Femoral Artery; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction

2008
The muscle-collagen ratio in left ventricular hypertrophy and aorta remodelling in hypertension.
    Acta physiologica (Oxford, England), 2008, Volume: 194, Issue:1

    Topics: Animals; Aorta; Collagen; Hypertension; Hypertrophy, Left Ventricular; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats

2008
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
    Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:9

    Topics: Animals; Blood Pressure; Cardiomegaly; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Signal Transduction; Simvastatin; Stroke Volume; Ultrasonography

2008
Regular exercise produced cardioprotective effects on rat's heart with hypertension induced by L-NAME administration.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2009, Volume: 31, Issue:4

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Disease Models, Animal; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Rats

2009
Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:4

    Topics: Abdomen; Animals; Aortic Coarctation; Arginine; Atrial Natriuretic Factor; Cardiovascular Agents; Disease Models, Animal; Endothelium; Ginsenosides; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Panax; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger

2010
The effect of indapamide on development of myocardial hypertrophy and fibrosis in L-NAME-induced hypertension in rat.
    Physiological research, 2011, Volume: 60, Issue:6

    Topics: Animals; Captopril; Collagen Type I; Collagen Type III; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar

2011
Short-term ACE inhibition confers long-term protection against target organ damage.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Proliferation; Creatinine; Disease Models, Animal; Enalapril; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Urea

2012
Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
    Japanese heart journal, 2003, Volume: 44, Issue:1

    Topics: Animals; Cardiac Output; Disease Progression; Enzyme Inhibitors; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Random Allocation; Ventricular Function, Left; Ventricular Remodeling

2003
Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Journal of hypertension, 2003, Volume: 21, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Collagen; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Mitochondria, Heart; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Predictive Value of Tests; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Treatment Outcome

2003
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
    Circulation research, 2004, May-14, Volume: 94, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olmesartan Medoxomil; Pilot Projects; Radiation Chimera; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Superoxide Dismutase; Tetrazoles; Up-Regulation

2004
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.
    Journal of hypertension, 2004, Volume: 22, Issue:5

    Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Mutant Strains; NG-Nitroarginine Methyl Ester; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Ventricular Function, Left

2004
Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
    Journal of hypertension, 2004, Volume: 22, Issue:8

    Topics: Alkadienes; Animals; Aortic Diseases; Blood Pressure; Blotting, Western; Carbon Radioisotopes; Enzyme Inhibitors; Flavonoids; Hypertension; Hypertrophy, Left Ventricular; Leucine; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Phenols; Polyphenols; Rats; Rats, Wistar; Vasoconstrictor Agents; Wine

2004
The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction.
    Pulmonary pharmacology & therapeutics, 2005, Volume: 18, Issue:1

    Topics: Animals; Aorta; Blood Pressure; Cardiac Output; Disease Models, Animal; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Ketanserin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Organ Size; Pulmonary Artery; Rabbits; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Stroke Volume; Ventricular Dysfunction, Left

2005
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:11

    Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Coronary Circulation; Echocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling

2004
L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    European journal of clinical investigation, 2005, Volume: 35, Issue:6

    Topics: Animals; Antihypertensive Agents; Arginine; Brain; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Ubiquinone

2005
Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
    Physiological research, 2007, Volume: 56 Suppl 2

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Diuretics; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Femoral Artery; Heart Ventricles; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Indapamide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents

2007
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Physiological research, 2007, Volume: 56 Suppl 2

    Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Muscle Proteins; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Spironolactone; Ventricular Remodeling

2007
Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Physiological research, 2007, Volume: 56 Suppl 2

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cell Proliferation; DNA Replication; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Remodeling

2007
Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training.
    Arquivos brasileiros de cardiologia, 2007, Volume: 89, Issue:2

    Topics: Adaptation, Physiological; Analysis of Variance; Animals; Blood Pressure; Disease Models, Animal; Endomyocardial Fibrosis; Enzyme Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Swimming

2007
Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.
    Pulmonary pharmacology & therapeutics, 2008, Volume: 21, Issue:3

    Topics: Animals; Blood Pressure; Caveolin 1; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Liver; Lung; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidants; Oxidative Stress; Phenotype; Physical Conditioning, Animal; Pulmonary Artery; Respiratory Function Tests; Signal Transduction; Superoxides

2008
Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Acta physiologica (Oxford, England), 2008, Volume: 194, Issue:1

    Topics: Animals; Aorta; Arginine; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone

2008
Renal hypertensive angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication.
    American journal of hypertension, 1995, Volume: 8, Issue:2

    Topics: Animals; Aorta; Arginine; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclic GMP; Desoxycorticosterone; Disease Models, Animal; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Mortality; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System

1995
Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Blood pressure. Supplement, 1994, Volume: 5

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Vascular Resistance

1994
Cardiac weight in hypertension induced by nitric oxide synthase blockade.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:3

    Topics: Angiotensins; Animals; Arginine; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Wistar; Renin; Time Factors

1993
Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    The Journal of clinical investigation, 1996, Aug-01, Volume: 98, Issue:3

    Topics: Animals; Arginine; Cyclic GMP; Dogs; Female; Guanylate Cyclase; Hypertrophy, Left Ventricular; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Oxygen Consumption

1996
Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to beta-adrenergic stimulation in normal dogs.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:2

    Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Coronary Circulation; Dogs; Female; Heart Rate; Hemodynamics; Hypertrophy, Left Ventricular; Isoproterenol; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide

1996
Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues.
    Physiological research, 1996, Volume: 45, Issue:4

    Topics: Animals; Aorta; Blood Pressure; Brain; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors

1996
Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Physiological research, 1996, Volume: 45, Issue:4

    Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Enzyme Inhibitors; Evaluation Studies as Topic; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors

1996
Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats.
    Physiological research, 1996, Volume: 45, Issue:4

    Topics: Animals; Blood Pressure; Carotid Arteries; Coronary Vessels; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Tunica Intima; Tunica Media

1996
Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase.
    Physiological research, 1996, Volume: 45, Issue:4

    Topics: Animals; Blood Pressure; Capillaries; Coronary Circulation; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Microcirculation; Muscle Fibers, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors

1996
Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation.
    Physiological research, 1996, Volume: 45, Issue:4

    Topics: Adrenergic Fibers; Animals; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Time Factors

1996
Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:6

    Topics: Animals; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy, Left Ventricular; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Mutant Strains; Rats, Wistar; Vascular Resistance

1997
Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
    American journal of hypertension, 1998, Volume: 11, Issue:6 Pt 1

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar

1998
Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Basic research in cardiology, 1998, Volume: 93, Issue:3

    Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Follow-Up Studies; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Random Allocation; Rats; Rats, Wistar; Ventricular Pressure

1998
ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1998, Volume: 21, Issue:4

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Combinations; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptor, Endothelin A; Time Factors

1998
Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
    General physiology and biophysics, 1999, Volume: 18 Suppl 1

    Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Stereoisomerism

1999
Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    European journal of pharmacology, 2000, Mar-10, Volume: 391, Issue:1-2

    Topics: Animals; Blood Pressure; Body Weight; Brain; Cardiomegaly; Enzyme Inhibitors; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar

2000
Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Collagen; DNA; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Muscle Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Renin-Angiotensin System; RNA; Ventricular Remodeling

2000
Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:7

    Topics: Aging; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Rate; Hemodynamics; Hindlimb; Hypertension; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Regional Blood Flow

2000
The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
    International journal of experimental pathology, 2001, Volume: 82, Issue:2

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cell Count; Enalapril; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plethysmography; Rats; Rats, Wistar; Statistics, Nonparametric; Verapamil

2001
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Circulation, 2001, Aug-14, Volume: 104, Issue:7

    Topics: Animals; Blood Pressure; Body Weight; Collagen; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time

2001
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibrosis; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Propranolol; Rats; Rats, Wistar; Time Factors

2002